findmyKOL
Clinical trialNCT02474407TerminatedPhase 2Interventional

Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)

SponsorAcorda TherapeuticsEnrollment78Refractory Epilepsy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Acorda Site #115

    Little Rock, Arkansas, United States

  • Acorda Site #127

    Washington D.C., District of Columbia, United States

  • Acorda Site #101

    Tampa, Florida, United States

  • Acorda Site #125

    Honolulu, Hawaii, United States

  • Acorda Site #104

    Lexington, Kentucky, United States

  • Acorda Site #111

    Baltimore, Maryland, United States

  • Acorda Site #102

    Bethesda, Maryland, United States

  • Acorda Site #110

    Ann Arbor, Michigan, United States

  • Acorda Site #117

    Jackson, Mississippi, United States

  • Acorda Site #112

    St Louis, Missouri, United States

  • Acorda Site #128

    Edison, New Jersey, United States

  • Acorda Site #121

    Hackensack, New Jersey, United States

  • Acorda Site #123

    Amherst, New York, United States

  • Acorda Site #119

    Rochester, New York, United States

  • Acorda Site #132

    Chapel Hill, North Carolina, United States

  • Acorda Site #114

    Portland, Oregon, United States

  • Acorda Site #105

    Philadelphia, Pennsylvania, United States

  • Acorda Site #116

    Philadelphia, Pennsylvania, United States

  • Acorda Site #130

    Memphis, Tennessee, United States

  • Acorda Site #103

    Bellaire, Texas, United States

  • Acorda Site #122

    Dallas, Texas, United States

  • Acorda Site #108

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2015
Primary completion
31 May 2016
Completion
31 Jul 2016
Last update posted
16 Oct 2018
Registered enrollment
78
Registry id
NCT02474407

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.